Leveraging modernization of the US influenza vaccine manufacturing base to make better vaccines: a work in progress

Vaccine Insights 2023; 2(4), 77–80

DOI: 10.18609/vac.2023.014

Published: 14 April 2023
Robert C Huebner

“The time is right to leverage our newly demonstrated manufacturing platforms to design and develop the next generation of influenza vaccines.”